Back to top
more

Cigna Group (CI)

(Real Time Quote from BATS)

$273.58 USD

273.58
37,330

+2.58 (0.95%)

Updated Aug 8, 2025 10:08 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 5% (231 out of 244)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Has Assurant (AIZ) Outpaced Other Finance Stocks This Year?

by Zacks Equity Research

Here is how Assurant (AIZ) and Cigna (CI) have performed compared to their sector so far this year.

Zacks Equity Research

Company News for May 9, 2022

by Zacks Equity Research

Companies in The News Are: TU, ENB, CI, UAA

Zacks Equity Research

Cigna (CI) Q1 Earnings Beat on High Membership, Ups '22 EPS View

by Zacks Equity Research

Cigna's (CI) first-quarter results gain momentum from strong performances in Evernorth and Cigna Healthcare segments. A raised EPS outlook for 2022 remains noteworthy.

Zacks Equity Research

Cigna (CI) Surpasses Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Cigna (CI) delivered earnings and revenue surprises of 17.15% and 1.23%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

CareTrust REIT (CTRE) Meets Q1 FFO Estimates

by Zacks Equity Research

CareTrust REIT (CTRE) delivered FFO and revenue surprises of 0% and 3.84%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Why Cigna (CI) Might Surprise This Earnings Season

by Zacks Equity Research

Cigna (CI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Zacks Equity Research

MetLife (MET) Q1 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

MetLife (MET) delivered earnings and revenue surprises of 27.61% and 3.52%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Cigna (CI) Eyes Q1 Earnings Beat on Cigna Healthcare Show

by Zacks Equity Research

Cigna's (CI) first-quarter 2022 results are likely to reflect improved pharmacy revenues in the Evernorth business.

Nalak Das headshot

5 Large-Cap Stocks to Buy Ahead of Q1 Earnings This Week

by Nalak Das

Five large-cap companies with a favorable Zacks Rank will report first-quarter earnings results this week. These are: CI, HST, BGNE, VRTX and EOG.

Zacks Equity Research

American International Group (AIG) Beats Q1 Earnings Estimates

by Zacks Equity Research

American International Group (AIG) delivered earnings and revenue surprises of 4.84% and 1.59%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Can Low Investment Income Spoil Lincoln (LNC) Q1 Earnings?

by Zacks Equity Research

Lincoln National's (LNC) first-quarter results are likely to reflect higher revenues from Annuities.

Zacks Equity Research

Allstate (ALL) to Post Q1 Earnings: Here's What You Should Know

by Zacks Equity Research

Allstate's (ALL) first-quarter results are likely to reflect lower net investment income.

Zacks Equity Research

Ball Corp (BLL) to Report Q1 Earnings: What's in the Offing?

by Zacks Equity Research

Ball Corp's (BLL) Q1 performance is likely to reflect benefits from solid demand for beverage can packaging, can plant capacity expansions and robust aerospace backlog.

Zacks Equity Research

MP Materials (MP) to Report Q1 Earnings: What's in Store?

by Zacks Equity Research

MP Materials' (MP) first-quarter 2022 results are likely to benefit from higher volumes sold, increased realized pricing and gains stemming from its efficiency improvements efforts.

Zacks Equity Research

Cameco Corp (CCJ) to Report Q1 Earnings: What to Expect?

by Zacks Equity Research

Cameco Corp's (CCJ) first-quarter 2022 results are likely to reflect higher average realized uranium prices, which will be offset by care and maintenance costs and operational readiness costs.

Zacks Equity Research

Alpha Metallurgical (AMR) to Post Q1 Earnings: What's in Store?

by Zacks Equity Research

Alpha Metallurgical Resources' (AMR) first-quarter 2022 results are likely to reflect higher coal prices as well as benefits from its cost control efforts and lower interest expense.

Zacks Equity Research

Cigna (CI) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

Cigna (CI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

AON Q1 Earnings & Sales Lag Estimates, Commercial Risk Betters

by Zacks Equity Research

AON expects more than mid-single-digit organic revenue growth for 2022.

Zacks Equity Research

What to Expect From American International (AIG) Q1 Earnings?

by Zacks Equity Research

American International Group's (AIG) first-quarter results are likely to reflect higher net premiums earned in General Insurance.

Zacks Equity Research

Aflac (AFL) Q1 Earnings Beat on Higher US Sales, Lower Costs

by Zacks Equity Research

Aflac (AFL) expects sales in Japan to improve in the second half of 2022.

Zacks Equity Research

Should Invesco S&P 500 GARP ETF (SPGP) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for SPGP

Zacks Equity Research

AON to Announce Q1 Earnings: What's in Store for the Stock?

by Zacks Equity Research

AON's first-quarter results are likely to reflect new business generation, growth in capital market transactions and increased operating costs.

Zacks Equity Research

Cboe Global (CBOE) to Post Q1 Earnings: What's in Store?

by Zacks Equity Research

Cboe Global's (CBOE) first-quarter results are likely to reflect higher demand for data and access solutions, strong proprietary products and contribution from acquisitions.

Zacks Equity Research

Is Cigna (CI) a Great Value Stock Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Has Cigna (CI) Outpaced Other Finance Stocks This Year?

by Zacks Equity Research

Here is how Cigna (CI) and Avidbank Holdings Inc. (AVBH) have performed compared to their sector so far this year.